• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

The effects of vaccination with inactivated uropathogenic bacteria in recurrent urinary tract infections of children.

作者信息

Nayir A, Emre S, Sirin A, Bulut A, Alpay H, Tanman F

机构信息

Department of Paediatric Nephrology, Istanbul University School of Medicine, Capa, Turkey.

出版信息

Vaccine. 1995 Aug;13(11):987-90. doi: 10.1016/0264-410x(95)00022-s.

DOI:10.1016/0264-410x(95)00022-s
PMID:8525693
Abstract

Secretory IgA (sIgA) is an important parameter in the predisposition to recurrent urinary tract infection (UTI). We investigated whether sIgA and frequency of UTI could be positively influenced by intramuscular vaccination with inactivated uropathogenic bacteria (Solco-Urovac). Ten otherwise healthy girls aged from 5 to 11 years (mean 9 1.7 years) with recurrent UTI were immunized with Solco-Urovac by i.m. injections three times at weekly intervals. A booster injection was given after 6 months. Urinary sIgA secretory component (SC) concentration was determined by radial immunodiffusion assay. Ten other age-matched girls with UTI were not immunized. Immunization therapy caused a significant reduction in the frequency of infection and an increase in urinary sIgA SC, while in the nonvaccinated group the values remained constant.

摘要

相似文献

1
The effects of vaccination with inactivated uropathogenic bacteria in recurrent urinary tract infections of children.
Vaccine. 1995 Aug;13(11):987-90. doi: 10.1016/0264-410x(95)00022-s.
2
Mucosal immunity in the urinary tract: changes in sIgA, FSC and total IgA with age and in urinary tract infection.尿路中的黏膜免疫:分泌型免疫球蛋白A、前向散射光和总免疫球蛋白A随年龄及尿路感染的变化
Clin Nephrol. 1997 Aug;48(2):69-78.
3
Role of the bacterial vaccine Solco-Urovac® in treatment and prevention of recurrent urinary tract infections of bacterial origin.细菌疫苗Solco-Urovac®在治疗和预防细菌性复发性尿路感染中的作用。
Georgian Med News. 2014 Jun(231):11-6.
4
Influence of Uro-Vaxom on sIgA level in urine in children with recurrent urinary tract infections.优洛加对复发性尿路感染患儿尿中分泌型免疫球蛋白A水平的影响。
Arch Immunol Ther Exp (Warsz). 1996;44(2-3):195-7.
5
Urinary IgA, secretory IgA and secretory component in women with recurrent urinary tract infections.
Nephron. 1990;56(1):50-5. doi: 10.1159/000186100.
6
Does low urinary sIgA predispose to urinary tract infection?低尿分泌型免疫球蛋白A会引发尿路感染吗?
Kidney Int. 1983 May;23(5):759-63. doi: 10.1038/ki.1983.90.
7
Urinary sIgA in children with urinary tract infection.尿路感染患儿的尿分泌型免疫球蛋白A
J Pediatr. 1986 Sep;109(3):416-21. doi: 10.1016/s0022-3476(86)80110-x.
8
[Prevention of recurrent urinary infections using Solco Urovac, a polymicrobial vaccine].[使用多微生物疫苗Solco Urovac预防复发性尿路感染]
Cas Lek Cesk. 1989 Aug 25;128(35):1106-9.
9
[Studies on urinary secretory IgA (SIgA). 1. Studies on SIgA in patients with urinary tract infections (author's transl)].
Nihon Hinyokika Gakkai Zasshi. 1981 Jul;72(7):810-27. doi: 10.5980/jpnjurol1928.72.7_810.
10
Elevated levels of secretory immunoglobulin A (sIgA) in urinary tract infections.尿路感染中分泌型免疫球蛋白A(sIgA)水平升高。
Indian J Pediatr. 2004 Jan;71(1):37-40. doi: 10.1007/BF02725654.

引用本文的文献

1
Vaccines against extraintestinal pathogenic (ExPEC): progress and challenges.针对肠外致病性大肠杆菌(ExPEC)的疫苗:进展与挑战。
Gut Microbes. 2024 Jan-Dec;16(1):2359691. doi: 10.1080/19490976.2024.2359691. Epub 2024 Jun 2.
2
A suspension of inactivated bacteria used for vaccination against recurrent urinary tract infections increases the phagocytic activity of murine macrophages.一种用于预防复发性尿路感染的细菌灭活悬液可提高鼠巨噬细胞的吞噬活性。
Front Immunol. 2023 Aug 16;14:1180785. doi: 10.3389/fimmu.2023.1180785. eCollection 2023.
3
Prospective multicentre randomized double-blind placebo-controlled parallel group study on the efficacy and tolerability of StroVac® in patients with recurrent symptomatic uncomplicated bacterial urinary tract infections.
StroVac® 在复发性有症状单纯性细菌性尿路感染患者中的疗效和耐受性的前瞻性多中心随机双盲安慰剂对照平行组研究。
Int Urol Nephrol. 2023 Jan;55(1):9-16. doi: 10.1007/s11255-022-03379-y. Epub 2022 Oct 1.
4
[Is there still no alternative to long-term antibacterial prophylaxis?].长期抗菌预防是否仍然没有替代方案?
Urologe A. 2020 Mar;59(3):255-260. doi: 10.1007/s00120-020-01139-3.
5
Update on Associated Risk Factors, Diagnosis, and Management of Recurrent Urinary Tract Infections in Children.儿童复发性尿路感染的相关危险因素、诊断和治疗的最新进展。
J Pediatric Infect Dis Soc. 2019 May 11;8(2):152-159. doi: 10.1093/jpids/piy065.
6
Drug and Vaccine Development for the Treatment and Prevention of Urinary Tract Infections.用于治疗和预防尿路感染的药物与疫苗研发
Microbiol Spectr. 2016 Feb;4(1). doi: 10.1128/microbiolspec.UTI-0013-2012.
7
Urinary tract infection in children.儿童尿路感染
BMJ Clin Evid. 2010 Feb 9;2010:0306.
8
Mucosal immunization with iron receptor antigens protects against urinary tract infection.用铁受体抗原进行黏膜免疫可预防尿路感染。
PLoS Pathog. 2009 Sep;5(9):e1000586. doi: 10.1371/journal.ppat.1000586. Epub 2009 Sep 18.